Resveratrol: A Focus on Several Neurodegenerative Diseases
Authors:
Open Access
- 9 June 2015
- journal article
- review article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2015, 1-14
Abstract
Molecules of the plant world are proving their effectiveness in countering, slowing down, and regressing many diseases. The resveratrol for its intrinsic properties related to its stilbene structure has been proven to be a universal panacea, especially for a wide range of neurodegenerative diseases. This paper evaluates (in vivo and in vitro) the various molecular targets of this peculiar polyphenol and its ability to effectively counter several neurodegenerative disorders such as Parkinson’s, Alzheimer’s, and Huntington’s diseases and amyotrophic lateral sclerosis. What emerges is that, in the deep heterogeneity of the pathologies evaluated, resveratrol through a convergence on the protein targets is able to give therapeutic responses in neuronal cells deeply diversified not only in morphological structure but especially in their function performed in the anatomical district to which they belong.Keywords
This publication has 157 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Secreted VAPB/ALS8 Major Sperm Protein Domains Modulate Mitochondrial Localization and Morphology via Growth Cone Guidance ReceptorsDevelopmental Cell, 2012
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP PhosphodiesterasesCell, 2012
- Understanding the role of TDP-43 and FUS/TLS in ALS and beyondCurrent Opinion in Neurobiology, 2011
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory networkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Alzheimer DiseaseDisease-a-Month, 2010
- AMP-activated protein kinase and its downstream transcriptional pathwaysCellular and Molecular Life Sciences, 2010
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK ActivationCell Metabolism, 2010
- Mitochondrial dysfunction in amyotrophic lateral sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiencyNeurotoxicity Research, 2008